Global prevalence and distribution of vancomycin resistant, vancomycin intermediate and heterogeneously vancomycin intermediate Staphylococcus aureus clinical …
Vancomycin-resistant Staphylococcus aureus (VRSA), Vancomycin-intermediate S. aureus
(VISA) and heterogeneous VISA (hVISA) are subject to vancomycin treatment failure. The …
(VISA) and heterogeneous VISA (hVISA) are subject to vancomycin treatment failure. The …
Envelope structures of Gram-positive bacteria
M Rajagopal, S Walker - Protein and sugar export and assembly in Gram …, 2017 - Springer
Gram-positive organisms, including the pathogens Staphylococcus aureus, Streptococcus
pneumoniae, and Enterococcus faecalis, have dynamic cell envelopes that mediate …
pneumoniae, and Enterococcus faecalis, have dynamic cell envelopes that mediate …
Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains …
BP Howden, JK Davies, PDR Johnson… - Clinical microbiology …, 2010 - Am Soc Microbiol
The emergence of vancomycin-intermediate Staphylococcus aureus (VISA) and
heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) over the past …
heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) over the past …
Daptomycin
M Heidary, AD Khosravi, S Khoshnood… - Journal of …, 2018 - academic.oup.com
Daptomycin is a cyclic lipopeptide antibiotic used for the treatment of Gram-positive
infections including complicated skin and skin structure infections, right-sided infective …
infections including complicated skin and skin structure infections, right-sided infective …
Mechanisms of drug resistance: daptomycin resistance
Daptomycin (DAP) is a cyclic lipopeptide with in vitro activity against a variety of Gram‐
positive pathogens, including multidrug‐resistant organisms. Since its introduction into …
positive pathogens, including multidrug‐resistant organisms. Since its introduction into …
Mechanisms of daptomycin resistance in Staphylococcus aureus: role of the cell membrane and cell wall
AS Bayer, T Schneider, HG Sahl - … of the New York Academy of …, 2013 - Wiley Online Library
The bactericidal, cell membrane–targeting lipopeptide antibiotic daptomycin (DAP) is an
important agent in treating invasive Staphylococcus aureus infections. However, there have …
important agent in treating invasive Staphylococcus aureus infections. However, there have …
A current perspective on daptomycin for the clinical microbiologist
RM Humphries, S Pollett… - Clinical microbiology …, 2013 - Am Soc Microbiol
Daptomycin is a lipopeptide antimicrobial with in vitro bactericidal activity against Gram-
positive bacteria that was first approved for clinical use in 2004 in the United States. Since …
positive bacteria that was first approved for clinical use in 2004 in the United States. Since …
Worldwide Epidemiology and Antibiotic Resistance of Staphylococcus aureus
M Monaco, F Pimentel de Araujo, M Cruciani… - … therapy and prophylaxis, 2017 - Springer
Staphylococcus aureus is an important human pathogen, responsible for infections in the
community and the healthcare setting. Although much of the attention is focused on the …
community and the healthcare setting. Although much of the attention is focused on the …
Daptomycin: mechanisms of action and resistance, and biosynthetic engineering
RH Baltz - Current opinion in chemical biology, 2009 - Elsevier
Daptomycin is a lipopeptide antibiotic used clinically to treat infections caused by Gram-
positive bacteria. Laboratory studies have shown that Staphylococcus aureus resistance to …
positive bacteria. Laboratory studies have shown that Staphylococcus aureus resistance to …
Broad‐spectrum antimicrobial peptide resistance by MprF‐mediated aminoacylation and flipping of phospholipids
Bacteria are frequently exposed to cationic antimicrobial peptides (CAMPs) from eukaryotic
hosts (host defence peptides) or from prokaryotic competitors (bacteriocins). However, many …
hosts (host defence peptides) or from prokaryotic competitors (bacteriocins). However, many …